… A traditional definition of congestive heart failure is “the inability of the heart to … heart failure
as we see it in clinical practice. The two major symptom complexes of congestive heart failure …

… to the eventual development of heart failure. As such, a potential added benefit of NHE1
inhibitors may include attenuation of the evolution of infarcted myocardium to failure. The aim of …

… Similar findings were reported by the New York Heart Failure Registry, with black HFpEF
patients also reporting worse renal function. These differences as recently reviewed by Shah …

… heart failure and hypertension. In contrast, K + channels have until now gained little recognition
as a site for therapeutic … nels ix controlling the membrane potential (and hence excitability…

… These advances have opened new avenues for the development of novel drugs targeting
the RAS to better treat hypertension and heart failure. Here we focus on new therapies in …

… the treatment of heart failure by targeting oxidative stress. Finally, we discuss the future potential
of … stress defence mechanisms, to improve clinical outcome in patients with heart failure. …

… This study sought to test the functional exercise capacity and endothelial function in a
cohort of chronic heart failure (CHF) patients treated with chronic type 5 phosphodiesterase (PDE …

… xercise intolerance is a major clinical manifestation in patients with chronic heart failure (CHF).
It was originally considered to be the result of a failure of perfusion to the exercising …

… ventricular diastolic function, detected by Doppler imaging, in patients with newly diagnosed
systolic heart failure (Hellenic Heart Failure Study). Heart Vessels. 2009; 24: 22-26. 39. …

… Genetic profiles may influence risk and prognosis as well as therapeutic options of heart
failure eg, defibrillator implantation in high risk mutations for hypertrophy. Heart failure patients …